Literature DB >> 2787385

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.

W F Owen1, M E Rothenberg, J Petersen, P F Weller, D Silberstein, A L Sheffer, R L Stevens, R J Soberman, K F Austen.   

Abstract

We report that the hypodense eosinophil population in three patients with corticosteroid-unresponsive IHES was uniquely long lived ex vivo in the absence of exogenous cytokines. Serum or plasma from these patients conferred prolonged viability ex vivo to normodense eosinophils from reference donors and converted them to a functionally activated hypodense phenotype. In that antibody against IL-5 neutralized this activity in IHES serum, excessive quantities of this cytokine may account for the characteristic eosinophilia and long-lived, functionally augmented eosinophil phenotype in this disorder.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787385      PMCID: PMC2189380          DOI: 10.1084/jem.170.1.343

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.

Authors:  N Harada; T Takahashi; M Matsumoto; T Kinashi; J Ohara; Y Kikuchi; N Koyama; E Severinson; Y Yaoita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Synthesis and release of leukotriene C4 by human eosinophils.

Authors:  W F Owen; R J Soberman; T Yoshimoto; A L Sheffer; R A Lewis; K F Austen
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

Review 3.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

4.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.

Authors:  L Prin; M Capron; A B Tonnel; O Bletry; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

5.  Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

Authors:  M E Rothenberg; W F Owen; D S Silberstein; J Woods; R J Soberman; K F Austen; R L Stevens
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.

Authors:  P C Tai; S J Ackerman; C J Spry; S Dunnette; E G Olsen; G J Gleich
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

Review 7.  Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells.

Authors:  C J Sanderson; H D Campbell; I G Young
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

8.  Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor.

Authors:  M E Rothenberg; J L Pomerantz; W F Owen; S Avraham; R J Soberman; K F Austen; R L Stevens
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

9.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

Authors:  I Winqvist; T Olofsson; I Olsson; A M Persson; T Hallberg
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

10.  Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

Authors:  W F Owen; M E Rothenberg; D S Silberstein; J C Gasson; R L Stevens; K F Austen; R J Soberman
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  44 in total

1.  IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production.

Authors:  H Ochi; N H De Jesus; F H Hsieh; K F Austen; J A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.

Authors:  W F Owen; J Petersen; D M Sheff; R D Folkerth; R J Anderson; J M Corson; A L Sheffer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 3.  Eosinophilic gastroenteritis with ascites: a case report and review of the literature.

Authors:  L M Fenoglio; V Benedetti; C Rossi; A Anania; K Wulhfard; M Trapani; E Scalabrino; G Alberto; D Novero; P Cavalloperin
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

4.  Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

Authors:  W F Owen; J Petersen; K F Austen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

Authors:  A P Sampson; R U Thomas; J F Costello; P J Piper
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 6.  Origin, regulation and physiological function of intestinal oeosinophils.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 7.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

8.  Mapping of the interleukin 5 receptor gene to human chromosome 3 p25-p26 and to mouse chromosome 6 close to the Raf-1 locus with polymorphic tandem repeat sequences.

Authors:  C O Jacob; K Mykytyn; T Varcony; H A Drabkin
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

9.  IL-5 in post-traumatic eosinophilic pleural effusion.

Authors:  L Schandené; B Namias; A Crusiaux; M Lybin; R Devos; T Velu; P Capel; R Bellens; M Goldman
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

10.  T cell lymphoid aggregates in bone marrow in idiopathic hypereosinophilic syndrome.

Authors:  J Metz; K M McGrath; H F Savoia; C G Begley; R Chetty
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.